Wells Fargo’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRX
DA
Wells Fargo's IMRX Position: Q3 2026 in Review
Wells Fargo reduced its Immuneering (IMRX) stake by 76% in Q3 2026, selling an estimated $169K and leaving 11,007 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5564.
Wells Fargo first reported a position in IMRX in Q3 2021 and has held it in 17 quarters since. The position peaked at $233K in Q2 2026. 127 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.
- Wells Fargo held 11,007 shares of Immuneering worth $45.1K as of Q3 2026.
- Wells Fargo sold 35,697 Immuneering shares in Q3 2026, an estimated $169K.
- Immuneering made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #5564 holding.
- Wells Fargo first reported a position in Immuneering in Q3 2021 and has held it in 17 quarters since.
- Wells Fargo's Immuneering position peaked at $233K in Q2 2026.
- 127 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.